HFA Premium Access

Vepoloxamer (purified poloxamer-188) improves LV function, limits cardiomyocyte calcium overload and restores integrity of calciu cycling proteins in myocardium of dogs with advanced heart failure

Congress Presentation

About the speaker

Professor Hani Sabbah

Henry Ford Hospital, Detroit (United States of America)
3 presentations
0 follower

5 more presentations in this session

Novel drugs in heart failure: what's on the horizon?

Speaker: Professor C. Maack (Wuerzburg, DE)


Effects of serelaxin on a systolic cardiac dysfunction induced by isoproterenol in mice with increased cardiac aldosterone

Speaker: Doctor G. Billebeau (Paris, FR)


Why treatment with natriuretic peptide analogs failed to fulfill our expectations? - receptor expression and function in a failing heart.

Speaker: Doctor K. Kodziszewska (Warsaw, PL)


ORM-3819 promotes cardiac contractility on a dual mechanism of action: troponin-C dependent calcium sensitization is supported by selective PDE III inhibition

Speaker: Doctor L. Nagy (Debrecen, HU)


Targeting HDACs in heart failure.


Access the full session

Novel drugs - how do they work?

Speakers: Professor H. Sabbah, Professor C. Maack, Doctor G. Billebeau, Doctor K. Kodziszewska, Doctor L. Nagy

About the event



21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb